Evli Likvidi vs UBS Lux Equity Fund Biotech USD

Evli Likvidi vs UBS Lux Equity Fund Biotech USD

1. Evli Likvidi

  • Security

    Evli Likvidi B

  • Fee

    0.31%

  • ISIN

    FI0008804463

  • Holdings

    9

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 13 holdings in Evli Likvidi, where the largest holding is Teollisuuden Voima (1.84), followed by Nordea (1.7) and Akelius (1.39). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in Evli Likvidi and UBS Lux Equity Fund Biotech USD.

Evli Likvidi UBS Lux Equity Fund Biotech USD
1. Teollisuuden Voima Oyj
Finland
1.84 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Nordea Bank Abp
Finland
1.7 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Akelius Residential D
Sweden
1.39 %
3. Moderna Inc
9.21 %
4. SSAB B
Sweden
1.2 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Stora Enso Oyj R
Finland
1.15 %
5. AbbVie Inc
USA
5.53 %
6. Luminor Bank AS
Estonia
1.14 %
6. Gilead Sciences Inc
USA
4.66 %
7. Skanska B
Sweden
1.06 %
7. Amgen Inc
4.3 %
8. Kojamo Oyj
Finland
1.06 %
8. BioNTech SE
4.13 %
9. Akelius Residential Property Finance BV
1.04 %
9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 5, 2025.